| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
, 25-Dihydroxyvitamin D3 Are Mediated by Increased Levels of p21 in the Prostatic Carcinoma Cell Line ALVA-311
University of Colorado Health Sciences Center, Department of Pathology, Denver, Colorado 80262
1
, 25-Dihydroxyvitamin D3 [1, 25-(OH)2D3] is recognized to have significant antiproliferative effects on certain prostatic carcinoma (PC) cell lines, although the precise mechanisms of action remain in question. We have evaluated the role of the cell cycle-dependent kinase inhibitor p21. In the PC cell lines ALVA-31 and LNCaP, 1, 25-(OH)2D3 inhibits growth and induces both p21 mRNA and protein levels. Growth inhibition of ALVA-31 cells was abolished by stable transfection with a p21 antisense construct. This effect was not attributable to a reduction in functional vitamin D receptors as measured by transcriptional activity with a luciferase-vitamin D response element reporter construct. Therefore, increased p21 expression appears necessary to mediate the antiproliferative effects of this hormone in ALVA-31 cells. Cell lines that are insensitive to the growth inhibitory properties of 1, 25-(OH)2D3 failed to up-regulate p21 expression after hormone treatment; these include sublines of ALVA-31 as well as the cell lines TSU-Pr1 and JCA-1. In the latter two lines, adenovirus-mediated expression of a sense p21 cDNA significantly reduced their proliferation as compared with a control adenoviral construct. This suggests that the signaling pathway downstream of p21 is intact in TSU-Pr1 and JCA-1 cells, although p21 expression appears unregulated by 1, 25-(OH)2D3. We propose a model in which the antiproliferative effect of 1, 25-(OH)2D3 on PC cells is mediated through increased p21 expression. Elucidation of why this effect is absent in select cell lines may provide valuable insight into the variability of responses observed in PC patients treated with vitamin D.
This article has been cited by other articles:
|
|
 |
|
  P. Sun, Y. Qiu, Z. Zhang, J. Wan, T. Wang, X. Jin, Q. Lan, N. Rothman, and Z.-l. Xia Association of Genetic Polymorphisms, mRNA Expression of p53 and p21 with Chronic Benzene Poisoning in a Chinese Occupational Population Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1821 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. P. Rohan and N. L. Weigel 1{alpha},25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer Cells Endocrinology, May 1, 2009; 150(5): 2046 - 2054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yin, J. Ni, M. Chen, Y. Guo, and S. Yeh RRR-{alpha}-Vitamin E Succinate Potentiates the Antitumor Effect of Calcitriol in Prostate Cancer without Overt Side Effects Clin. Cancer Res., January 1, 2009; 15(1): 190 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Peng, P. J. Malloy, J. Wang, and D. Feldman Growth Inhibitory Concentrations of Androgens Up-Regulate Insulin-Like Growth Factor Binding Protein-3 Expression via an Androgen Response Element in LNCaP Human Prostate Cancer Cells Endocrinology, October 1, 2006; 147(10): 4599 - 4607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, Z. Liu, E. M. Sturgis, Q. Shi, R. M. Chamberlain, M. R. Spitz, and Q. Wei Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck Carcinogenesis, September 1, 2005; 26(9): 1596 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Schwartz, D. Eads, A. Rao, S. D. Cramer, M. C. Willingham, T. C. Chen, D. P. Jamieson, L. Wang, K. L. Burnstein, M. F. Holick, et al. Pancreatic cancer cells express 25-hydroxyvitamin D-1{alpha}-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3 Carcinogenesis, June 1, 2004; 25(6): 1015 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. V. Stewart and N. L. Weigel Vitamin D and Prostate Cancer Experimental Biology and Medicine, April 1, 2004; 229(4): 277 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rao, A. Coan, J.-E. Welsh, W. W. Barclay, C. Koumenis, and S. D. Cramer Vitamin D Receptor and p21/WAF1 Are Targets of Genistein and 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cells Cancer Res., March 15, 2004; 64(6): 2143 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Han, N. Sidell, P. B. Fisher, and J. Roman Up-regulation of p21 Gene Expression by Peroxisome Proliferator-Activated Receptor {gamma} in Human Lung Carcinoma Cells Clin. Cancer Res., March 15, 2004; 10(6): 1911 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Davies, B. A. J. Evans, M. E. M. Jenney, and J. W. Gregory Effects of Chemotherapeutic Agents on the Function of Primary Human Osteoblast-Like Cells Derived from Children J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6088 - 6097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Prufer, C. Schroder, K. Hegyi, and J. Barsony Degradation of RXRs Influences Sensitivity of Rat Osteosarcoma Cells to the Antiproliferative Effects of Calcitriol Mol. Endocrinol., May 1, 2002; 16(5): 961 - 976. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
